Authors: Grimwade, D Du, MQ Langabeer, S Rogers, J Solomon, E

Citation: D. Grimwade et al., Screening for mutations of Bcl10 in leukaemia, BR J HAEM, 109(3), 2000, pp. 611-615

Authors: D'Sa, S Verfuerth, S Vyas, P Langabeer, S Perry, A Peniket, A Mackinnon, S

Citation: S. D'Sa et al., Early PCR-negativity after allogeneic BMT in adults with t(4;11) ALL in the absence of acute or chronic GVHD, BONE MAR TR, 23(7), 1999, pp. 695-696

Authors: Gari, M Goodeve, A Wilson, G Winship, P Langabeer, S Linch, D Vandenberghe, E Peake, I Reilly, J

Citation: M. Gari et al., c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia, BR J HAEM, 105(4), 1999, pp. 894-900

Authors: Allford, S Grimwade, D Langabeer, S Duprez, E Saurin, A Chatters, S Walker, H Roberts, P Rogers, J Bain, B Patterson, K McKernan, A Freemont, P Solomon, E Burnett, A Goldstone, A Linch, D

Citation: S. Allford et al., Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RAR alpha rearrangement in newly diagnosed AML, BR J HAEM, 105(1), 1999, pp. 198-207

Authors: Pallis, M Turzanski, J Harrison, G Wheatley, K Langabeer, S Burnett, AK Russell, NH

Citation: M. Pallis et al., Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia, BR J HAEM, 104(2), 1999, pp. 307-312